Drug & Supplement Interactions

Chromium + methylphenidate transdermal system

Brand names of methylphenidate transdermal system

  • Ritalin
  • Daytrana
  • Methylin
  • Metadate
  • Concerta
  • Quillivant
  • Aptensio
  • QuilliChew
  • Cotempla
  • Relexxii
  • Jornay

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated October 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line No Known Interaction

We found no known interaction between Chromium and methylphenidate transdermal system in our sources.

This also applies to Ritalin, Daytrana, Methylin and other brand names of methylphenidate transdermal system.

Still Worth Knowing

  • Shared side effects: Although there is no interaction, both can cause some of the same side effects. Taken together, those side effects might add up, and a new symptom can be harder to pin on one or the other.
See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Chromium with methylphenidate transdermal system. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Chromium and methylphenidate transdermal system Interaction Check

No Known Interaction Found

We did not find a documented interaction between methylphenidate transdermal system and Chromium in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

How We Checked

Why No Interaction Is Listed for methylphenidate transdermal system

We sort drugs into categories, such as blood thinners or antibiotics, and many supplement interactions are recorded for a whole category rather than for one drug. So we checked every category methylphenidate transdermal system is in against every category Chromium has a known interaction with.

5Categories methylphenidate transdermal system Is In
  • methylphenidate transdermal system by Name Interactions recorded for methylphenidate transdermal system itself rather than for a category. No Chromium Record
  • Stimulant Drugs Drugs that speed up the nervous system, such as amphetamine (Adderall), methylphenidate (Ritalin) and caffeine. No Chromium Record
  • Serotonergic Drugs Drugs that raise serotonin activity in the brain, such as many antidepressants (sertraline, fluoxetine), tramadol and triptans. No Chromium Record
  • Serotonergic Drugs Drugs that raise serotonin activity in the brain, such as many antidepressants (sertraline, fluoxetine), tramadol and triptans. No Chromium Record
  • Seizure Threshold Lowering Drugs Drugs that can make a seizure more likely in some people, such as bupropion, tramadol and some antibiotics. No Chromium Record
5Drug Categories Chromium Interacts With

No overlap. methylphenidate transdermal system is in none of the 5 categories Chromium interacts with, so no record links the two.

Still wondering about combining Chromium and methylphenidate transdermal system? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share
What to Watch For

Side Effects Chromium and methylphenidate transdermal system Have in Common

16 side effects show up for both Chromium and methylphenidate transdermal system.

  • Each has separately been linked to the effects below. Taken together, they might add up: the same side effect from two sources might be more likely or stronger. No study of the two together says by how much.
  • If one turns up, it can be harder to tell which one is behind it, so tell your pharmacist you take both.
  • 6 of them are worth acting on rather than waiting out, marked below.
  • Severe muscle breakdown Worth Acting On Additional detail

    Chromium

    Acute rhabdomyolysis has been reported for a previously healthy 24-year-old female who ingested chromium picolinate 1200 mcg over a 48-hour time period. Also, chromium polynicotinate has been associated with leg pain and paresthesia in patients taking the supplement to prevent weight gain during smoking cessation.

    Source: , the clinical database we license.

    2 references cited
    1. 42786. Martin, W. R. and Fuller, R. E. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998;18(4):860-862. DOI
    2. 42643. Parsons, A., Ingram, J., Inglis, J., Aveyard, P., Johnstone, E., Brown, K., Franklin, M., and Bermudez, I. A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to pr

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Seizures Worth Acting On Additional detail

    Chromium

    Orally, chromium picolinate may cause headache, paresthesia, insomnia, dizziness, and vertigo. Vague cognitive symptoms, slowed thought processes, and difficulty driving occurred on three separate occasions in a healthy 35-year-old male after oral intake of chromium picolinate 200-400 mcg.

    Source: , the clinical database we license.

    6 references cited
    1. 6860. Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body composition. J Sports Med Phys Fitness 1995;35:273-80.
    2. 10309. Davidson JR, Abraham K, Connor KM, McLeod MN. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry 2003;53:261-4.. PubMed
    3. 14325. Kleefstra N, Houweling ST, Jansman FG, et al. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2006;29: PubMed
    4. 42594. Pittler, M. H. and Ernst, E. Dietary supplements for body-weight reduction: a systematic review. Am.J.Clin Nutr. 2004;79(4):529-536. PubMed
    5. 42751. Huszonek, J. Over-the-counter chromium picolinate. Am J Psychiatry 1993;150(10):1560-1561. PubMed
    6. 2659. McLeod MN, Gaynes BN, Golden RN. Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients. J Clin Psych 1999;60:237-40. PubMed

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Anemia Worth Acting On Additional detail

    Chromium

    Anemia, hemolysis, and thrombocytopenia were reported in a 33 year-old female taking chromium picolinate 1200-2400 mcg daily for 4-5 months. The patient received supportive care, blood product transfusions, and hemodialysis and was stabilized and discharged a few days later. Lab values were normal at a one-year follow-up.

    Source: , the clinical database we license.

    1 reference cited
    1. 554. Cerulli J, Grabe DW, Gauthier I, et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-31. PubMed

    Another form of chromium, called hexavalent chromium, is unsafe. This type of chromium is a by-product of some manufacturing processes. Chronic exposure can cause liver, kidney, or cardiac failure, pulmonary complications, anemia, and hemolysis.

    Source: , the clinical database we license.

    6 references cited
    1. 9141. Lanca S, Alves A, Vieira AI, et al. Chromium-induced toxic hepatitis. Eur J Intern Med 2002;13:518-20. PubMed
    2. 11786. Food Standards Agency. Medicines and Healthcare products Regulatory Agency (MHRA). Expert Group on Vitamins and Minerals. Available at: http://cot.food.gov.uk/sites/default/files/vitmin2003.pdf.
    3. 42572. Gibb, H. J., Lees, P. S., Pinsky, P. F., and Rooney, B. C. Lung cancer among workers in chromium chemical production. Am J Ind.Med 2000;38(2):115-126. DOI
    4. 42573. Gibb, H. J., Lees, P. S., Pinsky, P. F., and Rooney, B. C. Clinical findings of irritation among chromium chemical production workers. Am J Ind.Med 2000;38(2):127-131. PubMed
    5. 42699. Xiang, J., Sun, Z., and Huan, J. N. Intensive chromic acid burns and acute chromium poisoning with acute renal failure. Chin Med.J.(Engl.) 7-5-2011;124(13):2071-2073.
    6. 42614. Hisatomi, K., Ishii, H., Hashiguchi, K., Seki, M., Ide, M., Sugiyama, K., Ishimoto, H., Nakayama, S., Mukae, H., and Kohno, S. Interstitial pneumonia caused by inhalation of fumes of nickel and chrome. Respirology. 2006;11(6):814-817. PubMed

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Hives Worth Acting On Additional detail

    Chromium

    Orally, chromium-containing supplements may cause acute generalized exanthematous pustulosis, skin rashes, and urticaria. Also, chromium picolinate or chromium chloride may cause systemic contact dermatitis when taken orally, especially in patients with contact allergy to chromium.

    Source: , the clinical database we license.

    6 references cited
    1. 42561. Young P, Turiansky G, Bonner M, and et al. Acute generalized exanthematous pustulosis induced by chromium picolinate. J.Am Acad.Dermatol. 1999;41(5 Pt 2):820-823. PubMed
    2. 42679. Krol, E., Krejpcio, Z., Byks, H., Bogdanski, P., and Pupek-Musialik, D. Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients. Biol.Trace Elem.Res. 2011;143(2):726-737.
    3. 17224. Yazaki Y, Faridi Z, Ma Y, et al. A pilot study of chromium picolinate for weight loss. J Altern Complement Med 2010;16:291-9. PubMed
    4. 6624. Fowler JF Jr. Systemic contact dermatitis caused by oral chromium picolinate. Cutis 2000;65:116. DOI
    5. 90058. De Marchi S, Cecchin E, De Marchi SU. Systemic allergic dermatitis resulting from oral administration of chromium with a food supplement. Contact Dermatitis 2014;70(2):123-5. PubMed
    6. 95096. Guimarães MM, Carvalho AC, Silva MS. Effect of chromium supplementation on the glucose homeostasis and anthropometry of type 2 diabetic patients: Double blind, randomized clinical trial: Chromium, glucose homeostasis and anthropometry. J Trace Elem Med Bi PubMed

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Liver problems Worth Acting On Additional detail

    Chromium

    Liver damage has been reported for a 33-year-old female taking chromium picolinate 1200 mcg daily for 4-5 months. Also, acute hepatitis has been reported in a patient taking chromium polynicotinate 200 mcg daily for 5 months. Symptoms resolved when the product was discontinued.

    Source: , the clinical database we license.

    3 references cited
    1. 554. Cerulli J, Grabe DW, Gauthier I, et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-31. PubMed
    2. 9141. Lanca S, Alves A, Vieira AI, et al. Chromium-induced toxic hepatitis. Eur J Intern Med 2002;13:518-20. PubMed
    3. 13037. Stevens T, Qadri A, Zein NN. Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. Ann Intern Med 2005;142:477-8. PubMed

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • A higher chance of infection Worth Acting On Additional detail

    Chromium

    Recorded for Chromium in the same Natural Medicines adverse-effect record shown under Anemia above.

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Mood changes or irritability Additional detail

    Chromium

    Orally, chromium picolinate has been associated with irritability and mood changes in patients taking the supplement to lose weight, while chromium polynicotinate has been associated with agitation and mood changes in patients taking the supplement to prevent weight gain during smoking cessation.

    Source: , the clinical database we license.

    2 references cited
    1. 6860. Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body composition. J Sports Med Phys Fitness 1995;35:273-80.
    2. 42643. Parsons, A., Ingram, J., Inglis, J., Aveyard, P., Johnstone, E., Brown, K., Franklin, M., and Bermudez, I. A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to pr

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Numbness or tingling Additional detail

    Chromium

    Recorded for Chromium in the same Natural Medicines adverse-effect record shown under Seizures above.

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Anxiety or restlessness Additional detail

    Chromium

    Recorded for Chromium in the same Natural Medicines adverse-effect record shown under Mood changes or irritability above.

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›
  • Reduced appetite Additional detail

    Chromium

    Orally, chromium in the form of chromium picolinate, chromium polynicotinate, chromium-containing brewer's yeast, or chromium-containing milk powder may cause nausea, vomiting, diarrhea, decreased appetite, constipation, flatulence, or gastrointestinal upset.

    Long-term exposure to heavy metals, including chromium, has been associated with increased risk of gallbladder disease and cancer.

    Source: , the clinical database we license.

    6 references cited
    1. 14325. Kleefstra N, Houweling ST, Jansman FG, et al. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2006;29: PubMed
    2. 42594. Pittler, M. H. and Ernst, E. Dietary supplements for body-weight reduction: a systematic review. Am.J.Clin Nutr. 2004;79(4):529-536. PubMed
    3. 42607. Pei, D., Hsieh, C. H., Hung, Y. J., Li, J. C., Lee, C. H., and Kuo, S. W. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Metabolism 2 PubMed
    4. 42622. Kleefstra, N., Houweling, S. T., Bakker, S. J., Verhoeven, S., Gans, R. O., Meyboom-de Jong, B., and Bilo, H. J. Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled tri DOI
    5. 42643. Parsons, A., Ingram, J., Inglis, J., Aveyard, P., Johnstone, E., Brown, K., Franklin, M., and Bermudez, I. A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to pr
    6. 42679. Krol, E., Krejpcio, Z., Byks, H., Bogdanski, P., and Pupek-Musialik, D. Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients. Biol.Trace Elem.Res. 2011;143(2):726-737.

    methylphenidate transdermal system

    Source: methylphenidate transdermal system’s

    It lists this side effect in its Adverse Reactions section.

    Read methylphenidate transdermal system’s label on DailyMed ›

Showing the 10 most notable of 16 shared effects — ranked by how unusual each one is, not just whether both lists mention it.

Reported for Chromium but not commonly for methylphenidate transdermal system: stomach upset, shortness of breath, a low platelet count and heart failure.

Note: Effects for methylphenidate transdermal system come from the Adverse Reactions section of its FDA label; effects for Chromium come from the Natural Medicines adverse-effect record, quoted above. The two sources word some effects differently, so we match them by meaning.

If You Decide to Take Both
  • Add one new thing at a time, and note the date you started it.
  • A start date turns “I’ve been feeling off” into something a pharmacist can work with.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.

Pharmacist Q&AYou ask. We answer.

Questions Our Pharmacists Have Answered About Chromium and methylphenidate transdermal system

Real questions from readers, each answered by a licensed pharmacist at HelloPharmacist, written by a person and not generated from a database. An answer is written for the reader who asked and their situation, so read it for what to ask your own pharmacist rather than as a plan to follow.

Each one covers Chromium or methylphenidate transdermal system, not necessarily both.

  1. The pharmacist says

    Glucoven's main ingredient berberine may increase bleeding risk when combined with baby aspirin, along with similar effects from alpha-lipoic acid in the product. Berberine can slow how your body processes metoprolol and losartan, potentially making metoprolol levels higher and losartan less effective, which deserves monitoring from your prescriber. Glucoven's ingredients all lower blood sugar and blood pressure, so combined with your current medications you should watch for dizziness when standing and be aware that metoprolol may mask early warning signs of low blood sugar. Talk with your doctor or pharmacist before starting this supplement to create a plan for watching your blood pressure, heart rate, and bleeding signs.

    Answered by Dr. Brian Staiger, PharmD · September 2026

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Chromium Does Interact With Other Medications

Chromium has 89 moderate, 89 minor known drug interactions in our database — methylphenidate transdermal system isn’t one of them. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Chromium

Covers the 2,830 medications we’ve checked against Chromium. Pick one to open its full report.

Alternatives for the Same Use

Other Supplements Studied for Diabetes, and How They Mix With methylphenidate transdermal system

Choosing a supplement while you take methylphenidate transdermal system? Here are other options studied for diabetes, and whether each has a documented interaction with methylphenidate transdermal system.

3 of them have a documented interaction with methylphenidate transdermal system: Black Seed (moderate), Caffeine (moderate) and Coffee (moderate).

26 other supplements have at least some evidence of a benefit for diabetes; the 8 below come first. Chromium itself is graded for it.

  • Black Seed Graded Moderate
  • Caffeine Graded Moderate
  • Coffee Graded Moderate
  • Aloe Graded No Known Interaction
  • Berberine Graded No Known Interaction
  • Blond Psyllium Graded No Known Interaction
  • Casein Peptides Graded No Known Interaction
  • Fenugreek Graded No Known Interaction

The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.

Everything Else You Take

See Every Supplement That Interacts With methylphenidate transdermal system

Take other supplements too? 68 supplements have a documented interaction with methylphenidate transdermal system, each explained on its page.

By severity: 5 major, 57 moderate and 6 minor.

The Most Serious There Right Now:

Open the methylphenidate transdermal system interaction pageEvery supplement checked against methylphenidate transdermal system, ranked by severity
One More Smart Check

Taking Chromium as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Chromium. We have broken down 16,728 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against methylphenidate transdermal system:

Get to Know Each One

About Chromium and methylphenidate transdermal system

Supplement

About Chromium

Chromium

Chromium is an essential trace mineral involved in how the body handles sugar and fat. Some studies suggest it may modestly help blood sugar control in certain people with type 2 diabetes, but results are mixed and the effect on weight loss is small and uncertain. For most healthy people who eat a varied diet, supplements are not needed; check with your pharmacist or doctor before starting.

Full Chromium guide: uses, dosage, safety and every interaction

On Its Own

Chromium Safety

Safety at a Glance

How Chromium Is Rated

  • Chromium Overall

    Use caution

    Usually well tolerated at typical supplement doses, but high or long-term doses may pose risks for some people.

  • Pregnancy

    Likely Safe

    When used orally and appropriately in amounts not exceeding adequate intake (AI) levels.

    Read the full pregnancy detail ↓
  • Breastfeeding

    Likely Safe

    When used orally and appropriately in amounts not exceeding adequate intake (AI) levels.

    Read the full breastfeeding detail ↓

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center), with the full detail in the next card.

Special Populations

Chromium in Pregnancy & Breastfeeding

Pregnancy Likely Safe

When used orally and appropriately in amounts not exceeding adequate intake (AI) levels. The AI for pregnancy is 28 mcg daily for those 14-18 years of age and 30 mcg daily for those 19-50 years of age.

Pregnancy Possibly Safe

When used orally in amounts exceeding the adequate intake (AI) levels. There is some evidence that patients with gestational diabetes can safely use chromium in doses of 4-8 mcg/kg; however, patients should not take chromium supplements during pregnancy without medical supervision.

Lactation Likely Safe

When used orally and appropriately in amounts not exceeding adequate intake (AI) levels. The AI for lactation is 44 mcg daily for those 14-18 years of age and 45 mcg daily for those 19-50 years of age. Chromium supplements do not seem to increase normal chromium concentration in human breast milk. There is insufficient reliable information available about the safety of chromium when used in higher amounts while breast-feeding.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Medication

About Methylphenidate Transdermal Patch

Brand names: Ritalin, Daytrana, Methylin, Metadate, Concerta, Quillivant, Aptensio, QuilliChew, Cotempla, Relexxii, Jornay

Methylphenidate Transdermal System (sold as Daytrana and as a generic Methylphenidate Transdermal System) treats ADHD in patients 6 to 17 years of age. It is a central nervous system (CNS) stimulant.

Methylphenidate Transdermal Patch: uses, dosage and side effects Methylphenidate Transdermal Patch: interactions with other drugs Taking more than these two? Check Chromium and Methylphenidate Transdermal Patch with everything else you take Methylphenidate NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Chromium

Browse every other medication we’ve checked against Chromium — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
89Moderate
89Minor
2,651No known interaction
Moderate

Moderate: 89 interactions

Showing 60 of 89 moderate interactions — see all 89 on the Chromium page.

Minor

Minor: 89 interactions

Showing 60 of 89 minor interactions — see all 89 on the Chromium page.

No Interaction 2,651 drugs checked — show the list
How Much People Look This Up

Where Chromium and methylphenidate transdermal system Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Chromium
Top 5%

#17 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication methylphenidate transdermal system
Top 10%

#162 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Chromium and methylphenidate transdermal system Together: Common Questions

Can you take Chromium with methylphenidate transdermal system?
We do not list a known interaction between Chromium and methylphenidate transdermal system. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Can you take Chromium with Ritalin?
Ritalin is a brand name of methylphenidate transdermal system, and so are Daytrana and Methylin, so the answer is the same as for methylphenidate transdermal system. We do not list a known interaction between Chromium and methylphenidate transdermal system. Everything on this page applies to Ritalin too.
Do Chromium and methylphenidate transdermal system have any of the same side effects?
Yes — our sources link each of them separately to 10 of the same effects. That is not a documented interaction, but taken together the same side effect from two sources might be more likely or stronger; no study of the two together says by how much. And if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
How was the Chromium and methylphenidate transdermal system combination checked?
Interactions in our licensed database are recorded against drug classes. methylphenidate transdermal system is filed under 5 classifications, and Chromium has documented interactions with 5 drug classes — none of methylphenidate transdermal system's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Do other supplements studied for diabetes interact with methylphenidate transdermal system?
3 of the 26 other supplements the Natural Medicines database grades as having some evidence of a benefit for diabetes have a documented interaction with methylphenidate transdermal system: Black Seed (moderate), Caffeine (moderate) and Coffee (moderate). A grade is the research so far, not a recommendation, and no known interaction is not proof of safety; ask your pharmacist before adding one.
Does Chromium interact with any other medications?
Yes. Chromium has 178 documented drug interactions in our database — methylphenidate transdermal system is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does methylphenidate transdermal system interact with any supplements?
Yes. methylphenidate transdermal system has documented interactions with 68 supplements in our database — Chromium is not one of them. The methylphenidate transdermal system interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 24 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 24 references
  1. 554. Cerulli J, Grabe DW, Gauthier I, et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-31. PubMed
  2. 2659. McLeod MN, Gaynes BN, Golden RN. Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients. J Clin Psych 1999;60:237-40. PubMed
  3. 6624. Fowler JF Jr. Systemic contact dermatitis caused by oral chromium picolinate. Cutis 2000;65:116. DOI
  4. 6860. Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body composition. J Sports Med Phys Fitness 1995;35:273-80.
  5. 9141. Lanca S, Alves A, Vieira AI, et al. Chromium-induced toxic hepatitis. Eur J Intern Med 2002;13:518-20. PubMed
  6. 10309. Davidson JR, Abraham K, Connor KM, McLeod MN. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry 2003;53:261-4.. PubMed
  7. 11786. Food Standards Agency. Medicines and Healthcare products Regulatory Agency (MHRA). Expert Group on Vitamins and Minerals. Available at: http://cot.food.gov.uk/sites/default/files/vitmin2003.pdf.
  8. 13037. Stevens T, Qadri A, Zein NN. Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. Ann Intern Med 2005;142:477-8. PubMed
  9. 14325. Kleefstra N, Houweling ST, Jansman FG, et al. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2006;29: PubMed
  10. 17224. Yazaki Y, Faridi Z, Ma Y, et al. A pilot study of chromium picolinate for weight loss. J Altern Complement Med 2010;16:291-9. PubMed
  11. 42561. Young P, Turiansky G, Bonner M, and et al. Acute generalized exanthematous pustulosis induced by chromium picolinate. J.Am Acad.Dermatol. 1999;41(5 Pt 2):820-823. PubMed
  12. 42572. Gibb, H. J., Lees, P. S., Pinsky, P. F., and Rooney, B. C. Lung cancer among workers in chromium chemical production. Am J Ind.Med 2000;38(2):115-126. DOI
  13. 42573. Gibb, H. J., Lees, P. S., Pinsky, P. F., and Rooney, B. C. Clinical findings of irritation among chromium chemical production workers. Am J Ind.Med 2000;38(2):127-131. PubMed
  14. 42594. Pittler, M. H. and Ernst, E. Dietary supplements for body-weight reduction: a systematic review. Am.J.Clin Nutr. 2004;79(4):529-536. PubMed
  15. 42607. Pei, D., Hsieh, C. H., Hung, Y. J., Li, J. C., Lee, C. H., and Kuo, S. W. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Metabolism 2 PubMed
  16. 42614. Hisatomi, K., Ishii, H., Hashiguchi, K., Seki, M., Ide, M., Sugiyama, K., Ishimoto, H., Nakayama, S., Mukae, H., and Kohno, S. Interstitial pneumonia caused by inhalation of fumes of nickel and chrome. Respirology. 2006;11(6):814-817. PubMed
  17. 42622. Kleefstra, N., Houweling, S. T., Bakker, S. J., Verhoeven, S., Gans, R. O., Meyboom-de Jong, B., and Bilo, H. J. Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled tri DOI
  18. 42643. Parsons, A., Ingram, J., Inglis, J., Aveyard, P., Johnstone, E., Brown, K., Franklin, M., and Bermudez, I. A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to pr
  19. 42679. Krol, E., Krejpcio, Z., Byks, H., Bogdanski, P., and Pupek-Musialik, D. Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients. Biol.Trace Elem.Res. 2011;143(2):726-737.
  20. 42699. Xiang, J., Sun, Z., and Huan, J. N. Intensive chromic acid burns and acute chromium poisoning with acute renal failure. Chin Med.J.(Engl.) 7-5-2011;124(13):2071-2073.
  21. 42751. Huszonek, J. Over-the-counter chromium picolinate. Am J Psychiatry 1993;150(10):1560-1561. PubMed
  22. 42786. Martin, W. R. and Fuller, R. E. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998;18(4):860-862. DOI
  23. 90058. De Marchi S, Cecchin E, De Marchi SU. Systemic allergic dermatitis resulting from oral administration of chromium with a food supplement. Contact Dermatitis 2014;70(2):123-5. PubMed
  24. 95096. Guimarães MM, Carvalho AC, Silva MS. Effect of chromium supplementation on the glucose homeostasis and anthropometry of type 2 diabetic patients: Double blind, randomized clinical trial: Chromium, glucose homeostasis and anthropometry. J Trace Elem Med Bi PubMed

All 54 references behind our Chromium records are listed in the Chromium guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The Chromium and methylphenidate transdermal system records this page draws on were last updated October 20, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Chromium and methylphenidate transdermal system?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.